{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:46:44Z","timestamp":1790819204648,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.trim.2006.10.006","type":"journal-article","created":{"date-parts":[[2006,11,30]],"date-time":"2006-11-30T15:10:51Z","timestamp":1164899451000},"page":"203-210","source":"Crossref","is-referenced-by-count":84,"title":["Quantitative analysis of EBV-specific CD4\/CD8 T cell numbers, absolute CD4\/CD8 T cell numbers and EBV load in solid organ transplant recipients with PLTD"],"prefix":"10.1016","volume":"17","author":[{"given":"Kathrin","family":"Sebelin-Wulf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuan D.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Oertel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Papp-Vary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf Ulrich","family":"Trappe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antje","family":"Schulzki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Pezzutto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanno","family":"Riess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Subklewe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trim.2006.10.006_bib1","series-title":"Fields virology","first-page":"2575","article-title":"Epstein Barr virus","author":"Rickinson","year":"2001"},{"key":"10.1016\/j.trim.2006.10.006_bib2","series-title":"Fields virology","first-page":"2511","article-title":"Epstein Barr virus","author":"Kieff","year":"2001"},{"key":"10.1016\/j.trim.2006.10.006_bib3","first-page":"147","article-title":"Occurrence of cancers in immunosuppressed organ transplant recipients","author":"Penn","year":"1998","journal-title":"Clin Transplant"},{"key":"10.1016\/j.trim.2006.10.006_bib4","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1200\/JCO.2001.19.3.772","article-title":"Identification of prognostic factors in 61 patients with posttransplantation lymphoproliferative disorders","volume":"19","author":"Leblond","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.trim.2006.10.006_bib5","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJM199404283301703","article-title":"Infusions of donor leukocytes to treat Epstein\u2013Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation","volume":"330","author":"Papadopoulos","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trim.2006.10.006_bib6","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1056\/NEJM199409083311017","article-title":"Donor T cells to treat EBV-associated lymphoma","volume":"331","author":"Heslop","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trim.2006.10.006_bib7","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1182\/blood.V92.5.1549","article-title":"Infusion of cytotoxic T cells for the prevention and treatment of Epstein\u2013Barr virus-induced lymphoma in allogeneic transplant recipients","volume":"92","author":"Rooney","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.trim.2006.10.006_bib8","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0140-6736(02)09672-1","article-title":"Treatment of Epstein\u2013Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells","volume":"360","author":"Haque","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.trim.2006.10.006_bib9","doi-asserted-by":"crossref","first-page":"S254","DOI":"10.1097\/01.tp.0000186382.81130.ba","article-title":"Malignancy after transplantation","volume":"80","author":"Buell","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2006.10.006_bib10","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1600-6143.2005.00776.x","article-title":"Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: the Israel Penn International Transplant Tumor Registry experience","volume":"5","author":"Trofe","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trim.2006.10.006_bib11","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/01.TP.0000079832.00991.EE","article-title":"Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy","volume":"76","author":"Gulley","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2006.10.006_bib12","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/01.TP.0000144335.39913.5C","article-title":"Differences between early and late posttransplant lymphoproliferative disorders in solid organ transplant patients: are they two different diseases?","volume":"79","author":"Ghobrial","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2006.10.006_bib13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1146\/annurev.immunol.15.1.405","article-title":"Human cytotoxic T lymphocyte responses to Epstein\u2013Barr virus infection","volume":"15","author":"Rickinson","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.trim.2006.10.006_bib14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1084\/jem.176.1.157","article-title":"Identification of target antigens for the human cytotoxic T cell response to Epstein\u2013Barr virus (EBV): implications for the immune control of EBV-positive malignancies","volume":"176","author":"Murray","year":"1992","journal-title":"J Exp Med"},{"key":"10.1016\/j.trim.2006.10.006_bib15","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1084\/jem.184.5.1801","article-title":"Epitope focusing in the primary cytotoxic T cell response to Epstein\u2013Barr virus and its relationship to T cell memory","volume":"184","author":"Steven","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.trim.2006.10.006_bib16","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1002\/(SICI)1521-4141(199912)29:12<3995::AID-IMMU3995>3.0.CO;2-E","article-title":"Presentation of Epstein\u2013Barr virus latency antigens to CD8(+), interferon-gamma-secreting, T lymphocytes","volume":"29","author":"Subklewe","year":"1999","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.trim.2006.10.006_bib17","doi-asserted-by":"crossref","first-page":"8649","DOI":"10.1128\/JVI.75.18.8649-8659.2001","article-title":"Differential immunogenicity of Epstein\u2013Barr virus latent-cycle proteins for human CD4(+) T-helper 1 responses","volume":"75","author":"Leen","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.trim.2006.10.006_bib18","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2174\/1566524033479771","article-title":"CD4+T cell responses in the immune control against latent infection by Epstein\u2013Barr virus","volume":"3","author":"Paludan","year":"2003","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.trim.2006.10.006_bib19","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1084\/jem.191.10.1649","article-title":"Human CD4(+) T lymphocytes consistently respond to the latent Epstein\u2013Barr virus nuclear antigen EBNA1","volume":"191","author":"Munz","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.trim.2006.10.006_bib20","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2006-05-023663","article-title":"Distinct memory CD4+T cell subsets mediate immune recognition of Epstein Barr virus nuclear antigen 1 in healthy virus carriers","author":"Heller","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.trim.2006.10.006_bib21","doi-asserted-by":"crossref","first-page":"12088","DOI":"10.1128\/JVI.77.22.12088-12104.2003","article-title":"Cytolytic CD4(+)-T-cell clones reactive to EBNA1 inhibit Epstein\u2013Barr virus-induced B-cell proliferation","volume":"77","author":"Nikiforow","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.trim.2006.10.006_bib22","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1002\/eji.200324794","article-title":"Epstein\u2013Barr virus nuclear antigen 1 evades direct immune recognition by CD4+T helper cells","volume":"34","author":"Mautner","year":"2004","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.trim.2006.10.006_bib23","doi-asserted-by":"crossref","first-page":"4896","DOI":"10.1128\/JVI.79.8.4896-4907.2005","article-title":"CD4+T-cell responses to Epstein\u2013Barr virus (EBV) latent-cycle antigens and the recognition of EBV-transformed lymphoblastoid cell lines","volume":"79","author":"Long","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.trim.2006.10.006_bib24","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1182\/blood-2005-01-0432","article-title":"Loss of EBNA1-specific memory CD4+and CD8+T cells in HIV-infected patients progressing to AIDS-related non-Hodgkin lymphoma","volume":"106","author":"Piriou","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.trim.2006.10.006_bib25","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1182\/blood.V99.11.3916","article-title":"Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy","volume":"99","author":"Einsele","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.trim.2006.10.006_bib26","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1172\/JCI0217214","article-title":"Adoptive therapy with CD8(+) T cells: it may get by with a little help from its friends","volume":"110","author":"Ho","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trim.2006.10.006_bib27","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/ni1105","article-title":"CD4+T cells are required for the maintenance, not programming, of memory CD8+T cells after acute infection","volume":"5","author":"Sun","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.trim.2006.10.006_bib28","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1172\/JCI22053","article-title":"Critical role of EBNA1-specific CD4+T cells in the control of mouse Burkitt lymphoma in vivo","volume":"114","author":"Fu","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trim.2006.10.006_bib29","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1182\/blood-2004-06-2336","article-title":"The magnitude and breadth of hepatitis C virus-specific CD8+T cells depend on absolute CD4+T-cell count in individuals coinfected with HIV-1","volume":"105","author":"Kim","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.trim.2006.10.006_bib30","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1084\/jem.20051287","article-title":"Control of Epstein\u2013Barr virus infection in vitro by T helper cells specific for virion glycoproteins","volume":"203","author":"Adhikary","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.trim.2006.10.006_bib31","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1097\/01.TP.0000131168.21930.5C","article-title":"Relationship between CD8+T-cell phenotype and function, Epstein\u2013Barr virus load, and clinical outcome in pediatric renal transplant recipients: a prospective study","volume":"77","author":"Baudouin","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2006.10.006_bib32","doi-asserted-by":"crossref","first-page":"4290","DOI":"10.1182\/blood-2002-10-3001","article-title":"Impaired recovery of Epstein\u2013Barr virus (EBV)-specific CD8+T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative disease","volume":"101","author":"Meij","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.trim.2006.10.006_bib33","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1097\/00007890-200205270-00014","article-title":"Ratio between Epstein\u2013Barr viral load and anti-Epstein\u2013Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease","volume":"73","author":"Smets","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2006.10.006_bib34","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/01.TP.0000093997.83754.2B","article-title":"Epstein\u2013Barr virus (EBV) reactivation in allogeneic stem-cell transplantation: relationship between viral load, EBV-specific T-cell reconstitution and rituximab therapy","volume":"77","author":"Clave","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2006.10.006_bib35","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1126\/science.274.5284.94","article-title":"Phenotypic analysis of antigen-specific T lymphocytes","volume":"274","author":"Altman","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.trim.2006.10.006_bib36","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1007\/s00277-006-0109-1","article-title":"Epstein\u2013Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course","volume":"85","author":"Oertel","year":"2006","journal-title":"Ann Hematol"},{"key":"10.1016\/j.trim.2006.10.006_bib37","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.trim.2005.02.001","article-title":"EBV-specific memory CD8+T cell phenotype and function in stable solid organ transplant patients","volume":"14","author":"Macedo","year":"2005","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.trim.2006.10.006_bib38","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1182\/blood.V99.7.2505","article-title":"Persistent numbers of tetramer+CD8(+) T cells, but loss of interferon-gamma+ HIV-specific T cells during progression to AIDS","volume":"99","author":"Kostense","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.trim.2006.10.006_bib39","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nri777","article-title":"Tracking T cells with tetramers: new tales from new tools","volume":"2","author":"Klenerman","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.trim.2006.10.006_bib40","doi-asserted-by":"crossref","first-page":"10302","DOI":"10.1073\/pnas.181348898","article-title":"Discrepancy between ELISPOT IFN-gamma secretion and binding of A2\/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide\/MHC complexes half-life","volume":"98","author":"Rubio-Godoy","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.trim.2006.10.006_bib41","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1084\/jem.192.12.1819","article-title":"Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children","volume":"192","author":"Goulder","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.trim.2006.10.006_bib42","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0022-1759(03)00265-5","article-title":"Sensitive and viable identification of antigen-specific CD8+T cells by a flow cytometric assay for degranulation","volume":"281","author":"Betts","year":"2003","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.trim.2006.10.006_bib43","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/35035103","article-title":"Immune control of HIV-1 after early treatment of acute infection","volume":"407","author":"Rosenberg","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.trim.2006.10.006_bib44","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0952-7915(00)00103-5","article-title":"The role of CD4(+) T helper cells in the cytotoxic T lymphocyte response to HIV-1","volume":"12","author":"Altfeld","year":"2000","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.trim.2006.10.006_bib45","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/eji.200425792","article-title":"Novel method for detection of virus-specific CD41+T cells indicates a decreased EBV-specific CD4+T cell response in untreated HIV-infected subjects","volume":"35","author":"Piriou","year":"2005","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.trim.2006.10.006_bib46","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1097\/00007890-199805150-00022","article-title":"CD4 lymphocytopenia as a risk factor for skin cancers in renal transplant recipients","volume":"65","author":"Ducloux","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.trim.2006.10.006_bib47","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1432-2277.2002.tb00187.x","article-title":"Lymphocyte subsets and assessment of cancer risk in renal transplant recipients","volume":"15","author":"Ducloux","year":"2002","journal-title":"Transpl Int"}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327406001444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966327406001444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T04:38:04Z","timestamp":1587271084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966327406001444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S0966327406001444"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2006.10.006","relation":{},"ISSN":["0966-3274"],"issn-type":[{"value":"0966-3274","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}